Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Enanta Pharmaceutica (ENTA)

Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot AP - Wed Feb 7, 3:07PM CST

Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

ENTA : 12.52 (+0.32%)
Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot AP - Mon Nov 20, 2023

Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

ENTA : 12.52 (+0.32%)
Why Shares of Enanta Pharmaceuticals Are Dropping Tuesday Motley Fool - Tue Aug 8, 2023

The company saw a slight revenue decline in its fiscal 2023 third-quarter earnings report.

JEF : 43.79 (+0.76%)
ABBV : 162.02 (-3.15%)
ENTA : 12.52 (+0.32%)
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot AP - Mon Aug 7, 2023

Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot

ENTA : 12.52 (+0.32%)
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates Zacks - Mon May 8, 2023

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of 6.28% and 9.60%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ENTA : 12.52 (+0.32%)
CATX : 1.5700 (-1.88%)
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot AP - Mon May 8, 2023

Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot

ENTA : 12.52 (+0.32%)
Enanta Pharmaceuticals Reports Positive Topline Results from Phase 2 SPRINT Trial Evaluating EDP-235 in Standard Risk Patients with COVID-19 Business Wire - Mon May 8, 2023

Enanta Pharmaceuticals, Inc . (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced topline data from SPRINT ( S ARS-Cov-2...

ENTA : 12.52 (+0.32%)
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET Business Wire - Mon May 8, 2023

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today reported financial results for its fiscal second...

ENTA : 12.52 (+0.32%)
Enanta Pharmaceuticals to Host Conference Call on May 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2023 Business Wire - Tue May 2, 2023

Enanta Pharmaceuticals, Inc . (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that it plans to report its financial...

ENTA : 12.52 (+0.32%)
Enanta Pharmaceuticals Announces Sale of a Portion of Global Royalties on MAVYRET® (U.S.)/MAVIRET® (ex-U.S.) (Glecaprevir/Pibrentasvir) to OMERS Life Sciences for $200 Million Business Wire - Tue Apr 25, 2023

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced the sale to OMERS, one of Canada’s...

ENTA : 12.52 (+0.32%)

Barchart Exclusives

5 Microcap Stocks With 65% or More Upside Potential Barchart - 14 minutes ago
While they do carry higher-than-average risk, these microcaps also offer major upside potential for investors seeking startup-sized returns. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot